Comparative Effectiveness of Biologic Agents Among Black and White Medicare Patients in the US With Metastatic Colorectal Cancer
Author:
Affiliation:
1. Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
2. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2787182/goel_2021_oi_211026_1638976960.72012.pdf
Reference45 articles.
1. Cancer statistics, 2021.;Siegel;CA Cancer J Clin,2021
2. Evolvement of the treatment paradigm for metastatic colon cancer: from chemotherapy to targeted therapy.;Aparo;Crit Rev Oncol Hematol,2012
3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.;Hurwitz;N Engl J Med,2004
4. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.;Tabernero;Lancet Oncol,2015
5. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.;Van Cutsem;J Clin Oncol,2012
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing;Genomics;2024-05
2. Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2023-10
3. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review;Cancer Causes & Control;2023-09-09
4. Molecular disparities in colorectal cancers of White Americans, Alabama African Americans, and Oklahoma American Indians;npj Precision Oncology;2023-08-19
5. Equitable Access to Clinical Trials: How Do We Achieve It?;American Society of Clinical Oncology Educational Book;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3